IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie (ABBV) company, announced the U.S. FDA approval of BOTOX ® Cosmetic for temporary improvement in the appearance of ...

Please provide your email address to receive an email when new articles are posted on . Botox Cosmetic temporarily decreases platysma muscle activity. It is the first product with four aesthetic ...

IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of BOTOX® Cosmetic for temporary improvement in the appearance ...

–All primary and secondary endpoints were met for second Phase 3 study (M21-310) and results were consistent with findings from first Phase 3 study (M21-309). –Results support onabotulinumtoxinA as a ...

IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of BOTOX ® Cosmetic for temporary improvement in the ...

Please provide your email address to receive an email when new articles are posted on . Platysma prominence treatment with 26 to 36 units of onabotulinumtoxinA was well-tolerated and had a favorable ...

(RTTNews) - Allergan Aesthetics, an AbbVie company (ABBV), announced that FDA approves BOTOX® Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting the ...

In both phase 3 trials, onabotulinumtoxinA significantly improved platysma band severity at maximum contraction compared with placebo. The Food and Drug Administration (FDA) has approved Botox ® ...

With the loss of elasticity in the skin that accompanies aging, platysma bands can become more apparent, protruding from the neck. While it’s not a medical issue, some people may wish to diminish ...